01
Harvest
At the hospital.
Tissue is collected through a minimally invasive liposuction procedure.
Redefining Reconstruction With Living Tissue Implants
Patient-derived, vascularized tissue implants for soft tissue reconstruction and aesthetic applications, starting with breast reconstruction. A living tissue implant, made from your own cells and connected to your body's blood supply, designed to last.
The Reality
1 in 8 women will face breast cancer.
Many will lose tissue to surgery. For many, the available options to rebuild what was lost do not feel acceptable.
0 %
Of women diagnosed with breast cancer will undergo mastectomy or lumpectomy.
0 %
Decline reconstruction entirely.
0 %
Re-operation rate for implants within 7 years.
The cost of inaction
Reconstruction is covered by federal law. Yet many women still walk away. Implants can require additional procedures over time and carry ongoing risks. Flap procedures are complex and involve surgery at multiple sites. For many patients, reconstruction becomes an ongoing burden rather than a step toward recovery.
The Diagnosis
Today's options fail women.
Two primary approaches exist, each with meaningful tradeoffs.
Synthetic Implants.
Foreign materials placed in the body. Often require additional procedures over time. Associated with risks such as rupture, capsular contracture, and recall.
Flap Surgery.
Transfers tissue from another part of the body. Complex procedures with recovery at both the breast and donor site. Not suitable or desirable for many patients.
Women don't need another compromise.They need a better option.
A New Approach
Three steps. Your cells. A personalized implant.
02
Build
At ReConstruct Bio.
Your cells are used to create a vascularized implant using proprietary 3D bioprinting technology developed at the Wyss Institute at Harvard.
03
Restore
In the operating room.
The implant is placed using microsurgical techniques and connected to blood vessels, enabling integration as living tissue.
Your cells. A personalized implant. No large donor-site surgery. Built to last.
Validation
Built on years of research at the Wyss Institute at Harvard.
- Rapid, sustained vascular integration demonstrated in vivo.
- Tissue survival beyond clinically relevant viability thresholds.
- In preliminary studies, over 60% of breast cancer survivors preferred a living tissue approach over current reconstruction options.
- Over $2M in non-dilutive funding supporting development.
Pedigree 
Outcomes
Better outcomes for everyone involved.
Patients, surgeons, and hospitals all benefit from the shift to living tissue.
Patients.
- Living tissue designed to integrate with the body.
- No large donor-site tissue transfer.
- Aims to improve long-term outcomes and quality of life.
Surgeons.
- Designed to fit within established microsurgical workflows.
- No large-volume tissue transfer.
- Potential for consistent and reproducible reconstruction.
Hospitals.
- Designed for integration within existing care pathways.
- Potential to expand reconstructive options.
- Aligned with long-term value-based care.
Survivorship should not come with lifelong compromise.
Many women describe reconstruction as an ongoing burden rather than closure. Repeated surgeries. Anxiety about implant safety. Outcomes that do not feel natural. ReConstruct Bio is focused on changing that by creating a solution that works with the body and supports long-term quality of life.